(VIMAB) VIMAB - Ratings and Ratios
Exchange: ST •
Country: Sweden •
Currency: SEK •
Type: Common Stock •
ISIN: SE0007439633
Technology, Software, Solutions, Cloud, Computing, Systems
Description: VIMAB VIMAB
Vimab Group AB (publ) is involved in management consulting activities in the areas of energy services, and industrial and environmental technology in Sweden and internationally. The company was incorporated in 2011 and is based in Stockholm, Sweden., Web URL: https://vimabgroup.com
Additional Sources for VIMAB Stock
VIMAB Stock Overview
| Market Cap in USD | 19m |
| Sector | Industrials |
| Industry | Consulting Services |
| GiC Sub-Industry | Research & Consulting Services |
| IPO / Inception |
VIMAB Stock Ratings
| Growth Rating | -38.9 |
| Fundamental | -35.1 |
| Dividend Rating | 1.0 |
| Rel. Strength | -35.3 |
| Analysts | - |
| Fair Price Momentum | 6.27 SEK |
| Fair Price DCF | - |
VIMAB Dividends
Currently no dividends paidVIMAB Growth Ratios
| Growth Correlation 3m | -85.4% |
| Growth Correlation 12m | -15% |
| Growth Correlation 5y | -61.7% |
| CAGR 5y | -9.35% |
| CAGR/Max DD 5y | -0.10 |
| Sharpe Ratio 12m | -1.01 |
| Alpha | -21.39 |
| Beta | -0.025 |
| Volatility | 82.61% |
| Current Volume | 26.6k |
| Average Volume 20d | 8.5k |
What is the price of VIMAB shares?
As of July 06, 2025, the stock is trading at SEK 7.14 with a total of 26,639 shares traded.
Over the past week, the price has changed by -1.71%, over one month by -14.43%, over three months by -17.11% and over the past year by -19.06%.
As of July 06, 2025, the stock is trading at SEK 7.14 with a total of 26,639 shares traded.
Over the past week, the price has changed by -1.71%, over one month by -14.43%, over three months by -17.11% and over the past year by -19.06%.
Is VIMAB a good stock to buy?
Probably not. Based on ValueRay´s Fundamental Analyses, VIMAB (ST:VIMAB) is currently (July 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -35.12 and therefor a somewhat negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VIMAB is around 6.27 SEK . This means that VIMAB is currently overvalued and has a potential downside of -12.18%.
Probably not. Based on ValueRay´s Fundamental Analyses, VIMAB (ST:VIMAB) is currently (July 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -35.12 and therefor a somewhat negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VIMAB is around 6.27 SEK . This means that VIMAB is currently overvalued and has a potential downside of -12.18%.
Is VIMAB a buy, sell or hold?
VIMAB has no consensus analysts rating.
VIMAB has no consensus analysts rating.
What are the forecasts for VIMAB share price target?
According to our own proprietary Forecast Model, VIMAB VIMAB will be worth about 6.8 in July 2026. The stock is currently trading at 7.14. This means that the stock has a potential downside of -5.18%.
According to our own proprietary Forecast Model, VIMAB VIMAB will be worth about 6.8 in July 2026. The stock is currently trading at 7.14. This means that the stock has a potential downside of -5.18%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 6.8 | -5.2% |